Literature DB >> 22507127

Regulation and cellular functions of class II phosphoinositide 3-kinases.

Marco Falasca1, Tania Maffucci.   

Abstract

Class II isoforms of PI3K (phosphoinositide 3-kinase) are still the least investigated and characterized of all PI3Ks. In the last few years, an increased interest in these enzymes has improved our understanding of their cellular functions. However, several questions still remain unanswered on their mechanisms of activation, their specific downstream effectors and their contribution to physiological processes and pathological conditions. Emerging evidence suggests that distinct PI3Ks activate different signalling pathways, indicating that their functional roles are probably not redundant. In the present review, we discuss the recent advances in our understanding of mammalian class II PI3Ks and the evidence suggesting their involvement in human diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22507127     DOI: 10.1042/BJ20120008

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  60 in total

1.  Class II but Not Second Class-Prospects for the Development of Class II PI3K Inhibitors.

Authors:  Simon J Mountford; Zhaohua Zheng; Krithika Sundaram; Ian G Jennings; Justin R Hamilton; Philip E Thompson
Journal:  ACS Med Chem Lett       Date:  2014-09-24       Impact factor: 4.345

Review 2.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 3.  Classes of phosphoinositide 3-kinases at a glance.

Authors:  Steve Jean; Amy A Kiger
Journal:  J Cell Sci       Date:  2014-03-01       Impact factor: 5.285

4.  High-Throughput Small Interfering RNA Screening Identifies Phosphatidylinositol 3-Kinase Class II Alpha as Important for Production of Human Cytomegalovirus Virions.

Authors:  William S Polachek; Hanan F Moshrif; Michael Franti; Donald M Coen; Vattipally B Sreenu; Blair L Strang
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

5.  Plentiful PtdIns5P from scanty PtdIns(3,5)P2 or from ample PtdIns? PIKfyve-dependent models: Evidence and speculation (response to: DOI 10.1002/bies.201300012).

Authors:  Assia Shisheva; Diego Sbrissa; Ognian Ikonomov
Journal:  Bioessays       Date:  2014-11-18       Impact factor: 4.345

6.  A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.

Authors:  Chinmay Satish Rahane; Arne Kutzner; Klaus Heese
Journal:  J Neurooncol       Date:  2018-11-09       Impact factor: 4.130

7.  Phosphatidylinositol 3,4-bisphosphate regulates neurite initiation and dendrite morphogenesis via actin aggregation.

Authors:  Shu-Xin Zhang; Li-Hui Duan; Shun-Ji He; Gui-Feng Zhuang; Xiang Yu
Journal:  Cell Res       Date:  2017-01-20       Impact factor: 25.617

Review 8.  Role of phosphoinositide 3-kinase in the pathogenesis of acute pancreatitis.

Authors:  Enrico Lupia; Luca Pigozzi; Alberto Goffi; Emilio Hirsch; Giuseppe Montrucchio
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

9.  Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.

Authors:  Charlotte E Edling; Federico Selvaggi; Ragheda Ghonaim; Tania Maffucci; Marco Falasca
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

10.  Gene expression in skeletal muscle after an acute intravenous GH bolus in human subjects: identification of a mechanism regulating ANGPTL4.

Authors:  Berthil F F Clasen; Thomas Krusenstjerna-Hafstrøm; Mikkel Holm Vendelbo; Kasper Thorsen; Carlos Escande; Niels Møller; Steen B Pedersen; Jens Otto L Jørgensen; Niels Jessen
Journal:  J Lipid Res       Date:  2013-04-20       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.